FDXR Antibody (C-term) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P22570 |
---|---|
Clone Names | 100528070 |
Gene ID | 2232 |
---|---|
Other Names | NADPH:adrenodoxin oxidoreductase, mitochondrial, AR, Adrenodoxin reductase, Ferredoxin--NADP(+) reductase, Ferredoxin reductase, FDXR, ADXR |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | FDXR (HGNC:3642) |
---|---|
Synonyms | ADXR |
Function | Serves as the first electron transfer protein in all the mitochondrial P450 systems including cholesterol side chain cleavage in all steroidogenic tissues, steroid 11-beta hydroxylation in the adrenal cortex, 25-OH-vitamin D3-24 hydroxylation in the kidney, and sterol C- 27 hydroxylation in the liver. |
Cellular Location | Mitochondrion inner membrane {ECO:0000250|UniProtKB:P48360}; Peripheral membrane protein |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a mitochondrial flavoprotein thatinitiates electron transport for cytochromes P450 receivingelectrons from NADPH. Multiple alternatively spliced transcriptvariants of this gene have been described although the full-lengthnature of only two that encode different isoforms have beendetermined.
References
Trapasso, F., et al. J. Biol. Chem. 283(20):13736-13744(2008)Araya, Z., et al. Biochim. Biophys. Acta 1632 (1-3), 40-47 (2003) :Thiboutot, D., et al. J. Invest. Dermatol. 120(6):905-914(2003)Liu, G., et al. Oncogene 21(47):7195-7204(2002)Coghlan, V.M., et al. J. Biol. Chem. 266(28):18606-18612(1991)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.